NCT02969408 - A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma | Biotech Hunter

Enrollment

397

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

February 2, 2018

Study Completion Date

February 2, 2018

Conditions

Asthma

Interventions

DRUG

Albuterol Sulfate

Albuterol sulfate will be administered as per the dose and schedule specified in the arm.

Trial Locations (44)

14618

Teva Investigational Site 13945, Rochester

22030

Teva Investigational Site 13956, Fairfax

27262

Teva Investigational Site 13936, High Point

29303

Teva Investigational Site 13938, Spartanburg

29407

Teva Investigational Site 13929, Charleston

29607

Teva Investigational Site 13941, Greenville

29615

Teva Investigational Site 13951, Greenville

31406

Teva Investigational Site 13963, Savannah

32174

Teva Investigational Site 13931, Ormond Beach

32803

Teva Investigational Site 13948, Orlando

32819

Teva Investigational Site 13934, Orlando

33176

Teva Investigational Site 13942, Miami

33186

Teva Investigational Site 13927, Miami

33470

Teva Investigational Site 13921, Loxahatchee Groves

33765

Teva Investigational Site 13946, Clearwater

34239

Teva Investigational Site 13926, Sarasota

37909

Teva Investigational Site 13924, Knoxville

41017

Teva Investigational Site 13958, Fort Mitchell

42301

Teva Investigational Site 13940, Owensboro

45231

Teva Investigational Site 13953, Cincinnati

46360

Teva Investigational Site 13943, Michigan City

59808

Teva Investigational Site 13919, Missoula

63141

Teva Investigational Site 13965, St Louis

66210

Teva Investigational Site 13925, Overland Park

73034

Teva Investigational Site 13928, Edmond

73131

Teva Investigational Site 13955, Oklahoma City

75231

Teva Investigational Site 13920, Dallas

77099

Teva Investigational Site 13930, Houston

78006

Teva Investigational Site 13962, Boerne

78230

Teva Investigational Site 13939, San Antonio

78251

Teva Investigational Site 13957, San Antonio

80112

Teva Investigational Site 13933, Centennial

85340

Teva Investigational Site 13964, Litchfield Park

90048

Teva Investigational Site 13954, Los Angeles

92506

Teva Investigational Site 13961, Riverside

92868

Teva Investigational Site 13923, Orange

93301

Teva Investigational Site 13959, Bakersfield

04401

Teva Investigational Site 13937, Bangor

68123-4303

Teva Investigational Site 13947, Bellevue

08724

Teva Investigational Site 13960, Brick

08854

Teva Investigational Site 13932, Piscataway

07044

Teva Investigational Site 13922, Verona

02914

Teva Investigational Site 13949, East Providence

05403

Teva Investigational Site 13952, South Burlington

All Listed Sponsors

lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY